[FOLD] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[FOLD] Amicus Therapeutics, Inc.
Announcement Date
28-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 35.92%
Quarter Report
FOLD's Result
FOLD's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 399,356 329,233 305,514 260,886 182,237 91,245 36,930 48.67%
PBT -150,101 -242,039 -241,554 -274,254 -355,910 -349,089 -449,121 -16.68%
Tax 1,483 -5,471 8,906 2,598 478 -94 -165,119 -
NP -151,584 -236,568 -250,460 -276,852 -356,388 -348,995 -284,002 -9.93%
Tax Rate - - - - - - - -
Total Cost 550,940 565,801 555,974 537,738 538,625 440,240 320,932 9.42%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -37.96 -71.85 -81.98 -106.12 -195.56 -382.48 -769.03 -39.41%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.51 -0.82 -0.92 -1.07 -1.48 -1.88 -1.85 -19.31%
EPS Diluted -0.51 -0.82 -0.92 -1.07 -1.48 -1.88 -1.85 -19.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.